Skip to main content
SpringerLink
Log in

Yellow Fever

  • Chapter
  • First Online:
Arthropod Borne Diseases

Abstract

Yellow fever remains as an important threat in sub-Saharan Africa and South America, the regions where it is endemic; the yellow fever virus has periodically stricken human and nonhuman primates’ population, its urban and jungle hosts, when epidemics and/or epizootics are registered, respectively. These periodic expansions and retractions in both endemic regions are not completely understood, but several factors play a role including a heavy rainy season, the number of vectors, and the level of immunity coverage conferred by 17D vaccine use. The mosquito vectors are different for urban and jungle cycles for Africa and South America, and several sylvatic Aedes and Haemagogus species are its vectors, respectively. In urban settings the only vector is the peri-domestic Aedes aegypti. Nonetheless, only in Africa a third intermediate (rural) cycle is vectored by Aedes simpsoni. The diagnostic of yellow fever is made by molecular approaches (RT-PCR and real-time RT-PCR), virus isolation (cell culture), serology (IgM-ELISA), and immunohistochemical assay on tissue of fatal cases. Treatment is only supportive, and the prevention should be focused on vaccination of people living in or moving to endemic areas. These aspects are discussed in this chapter. Although several taxonomic modifications have been proposed on Culicidae genera, mostly splitting Aedes mosquitoes into different genera, this taxonomy putting all Aedes in a single genus has been used in the yellow fever chapter. To facilitate utilization by health personnel, all new aedine genera can be considered Aedes (CBM).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Allergy to egg products precludes the utilization of this vaccine.

References

  • Almeida MAB, Cardoso JA, Santos E et al (2014) Surveillance for yellow fever virus in non-human primates in southern Brazil, 2001–2011: a tool for prioritizing human populations for vaccination. PLoS Negl Trop Dis 8, e2741. doi:10.1371/journal.pntd.0002741

    Article  PubMed  PubMed Central  Google Scholar 

  • Barrett AD, Higgs S (2007) Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol 52:209–229

    Article  CAS  PubMed  Google Scholar 

  • Bryant JE, Holmes EC, Barrett AD (2007) Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog 3, e75

    Article  PubMed  PubMed Central  Google Scholar 

  • Cardoso JC, Almeida MAB, Santos E et al (2010) Yellow fever virus isolation from Haemagogus leucocelaenus and Aedes serratus mosquitoes, southern Brazil, 2008. Emerg Infect Dis 16:1918–1924

    Article  PubMed Central  Google Scholar 

  • Chambers TJ, Hahn CS, Galler R et al (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649–688

    Article  CAS  PubMed  Google Scholar 

  • Chan RC, Penney DJ, Little D et al (2001) Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358:121–122

    Article  CAS  PubMed  Google Scholar 

  • Garske T, Van Kerkhove MD, Yactayo S et al (2013) Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med 11(5), e1001638. doi:10.1371/journal.pmed.1001638

    Article  Google Scholar 

  • Germain M, Francy DB, Monath TP et al (1980) Yellow fever in the Gambia, 1978–1979: entomological aspects and epidemiological correlations. Am J Trop Med Hyg 29:929–940

    CAS  PubMed  Google Scholar 

  • Gershman MD, Staples JE, Bentsi-Enchill AD et al (2012) Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 30:5038–5058

    Article  PubMed  PubMed Central  Google Scholar 

  • Goenaga S, Fabbri C, Dueñas JC et al (2012) Isolation of yellow fever virus from mosquitoes in Misiones province, Argentina. Vector Borne Zoonotic Dis 12:986–993

    Article  PubMed  Google Scholar 

  • Gubler DJ, Kuno G, Markoff L (2007) Flaviviruses. In: Knipe DM, Howley PM, Griffin DE et al (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins Publishers, Philadelphia, PA, pp 1153–1252

    Google Scholar 

  • Jentes EJ, Poumerol G, Gershman MD et al (2011) The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11:622–632

    Article  PubMed  Google Scholar 

  • Johansson MA, Vasconcelos PF, Staples JE (2014) The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases. Trans R Soc Trop Med Hyg 108:482–487

    Article  PubMed  PubMed Central  Google Scholar 

  • Julander JG, Ennis J, Turner J et al (2011) Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrob Agents Chemother 55:2067–2073

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Markoff L (2013) Yellow fever outbreak in Sudan. N Engl J Med 368:689–691

    Article  CAS  PubMed  Google Scholar 

  • Martin M, Tsai TF, Cropp B et al (2001) Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 358:98–104

    Article  CAS  PubMed  Google Scholar 

  • Monath TP (2001) Yellow fever: an update. Lancet Infect Dis 1:11–20

    Article  CAS  PubMed  Google Scholar 

  • Monath TP (2008) Treatment of yellow fever. Antiviral Res 78:116–124

    Article  CAS  PubMed  Google Scholar 

  • Monath TP, Barrett ADT (2003) Pathogenesis and pathophysiology of yellow fever. Adv Virus Dis 60:343–395

    Article  Google Scholar 

  • Monath TP, Vasconcelos PF (2015) Yellow fever. J Clin Virol 64:160–173. doi:10.1016/j.jcv.2014.08.030

    Article  PubMed  Google Scholar 

  • Monath TP, Onejeme S, Okweke G et al (1972) Surveillance of yellow fever in Nigeria, 1970–1971. Niger Med J21:178–186

    Google Scholar 

  • Monath TP, Nichols R, Archamboult W et al (2002) Comparative safety of two yellow fever 17D vaccines (Arilvax and YF-Vax) in a phase III multicenter, double-blind clinical trial. Am J Trop Med Hyg 66:533–541

    CAS  PubMed  Google Scholar 

  • Monath TP, Gershman M, Staples EJ et al (2012) Yellow fever vaccine. In: Plotkin SA, Orenstein WA et al (eds) Vaccines, chapter 36, 6th edn. Saunders Elsevier, Philadelphia, pp 870–896

    Google Scholar 

  • Moreno ES, Spinola R, Tengan CH et al (2013) Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008–2009. Rev Inst Med Trop Sao Paulo 55:45–50

    Article  PubMed  Google Scholar 

  • Mutebi J-P, Wang H, Li L et al (2001) Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol 75:6999–7008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nunes MRT, Palacios G, Nunes KNB et al (2011) Evaluation of two molecular methods for the detection of Yellow fever virus genome. J Virol Meth 174:29–34

    Article  CAS  Google Scholar 

  • Quaresma JAS, Barros VLRS, Fernandes ER et al (2005) Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Trop 94:116–127

    Article  PubMed  Google Scholar 

  • Quaresma JAS, Barros VLRS, Pagliari C et al (2006a) Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-β, TNFα, and NK cells activity. Virology 345:22–30

    Article  CAS  PubMed  Google Scholar 

  • Quaresma JAS, Barros VLRS, Pagliari C et al (2006b) Immunohistochemical examination of the role of FAS Ligand and lymphocytes in the pathogenesis of human liver Yellow fever. Virus Res 116:91–97

    Article  CAS  PubMed  Google Scholar 

  • Quaresma JAS, Duarte MIS, Vasconcelos PFC (2006c) Midzonal lesion in the yellow fever: a specific pattern of liver injury caused by direct virus action and by immune anti-inflammatory response. Med Hypotheses 47:618–621

    Article  Google Scholar 

  • Quaresma JAS, Barros VLRS, Fernandes ER et al (2007) Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg 101:161–168

    Article  PubMed  Google Scholar 

  • Quaresma JAS, Pagliari C, Medeiros DBA et al (2013) Immunity and immune response, pathology and pathologic changes. Progresses and challenges in the immunopathology of yellow fever. Rev Med Virol 23:305–331

    Article  CAS  PubMed  Google Scholar 

  • Rice C, Lenches EM, Eddy SR et al (1985) Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229(4715):726–733

    Article  CAS  PubMed  Google Scholar 

  • Robertson SE, Hull BP, Tomori O et al (1996) Yellow fever: a decade of reemergence. JAMA 276:1157–1162

    Article  CAS  PubMed  Google Scholar 

  • Romano AP, Costa ZA, Ramos DG (2014) Yellow fever outbreaks in unvaccinated populations, Brazil, 2008–2009. PLoS Negl Trop Dis 8(3), e2740. doi:10.1371/journal.pntd.0002740

    Article  PubMed  PubMed Central  Google Scholar 

  • Sall AA, Faye O, Diallo M et al (2010) Yellow fever exhibits slower evolutionary dynamics than dengue virus. J Virol 84:765–772

    Article  CAS  PubMed  Google Scholar 

  • Seligman SJ (2011) Yellow fever virus vaccine—associated deaths in young women. Emerg Infect Dis 17:1891–1893

    Article  PubMed  PubMed Central  Google Scholar 

  • Souza RP, Foster PG, Sallum MA et al (2010) Detection of a new yellow fever virus lineage within the South American genotype I in Brazil. J Med Virol 82:175–185

    Article  PubMed  Google Scholar 

  • Tuboi SH, Costa ZGA, Vasconcelos PFC et al (2007) Clinical and epidemiologic characteristics of yellow fever in Brazil: analysis of reported cases, 1998–2002. Trans R Soc Trop Med Hyg 101:169–175

    Article  PubMed  Google Scholar 

  • Vasconcelos PFC (2010) Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas. Rev Saude Publica 44:1144–1149

    Article  PubMed  Google Scholar 

  • Vasconcelos PF, Luna EJ, Galler R et al (2001a) Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 358:91–97

    Article  CAS  PubMed  Google Scholar 

  • Vasconcelos PFC, Costa ZG, Travassos da Rosa ES et al (2001b) An epidemic of jungle yellow fever in Brazil, 2000. Implications of climatic alterations in disease spread. J Med Virol 65:598–604

    Article  CAS  PubMed  Google Scholar 

  • Vasconcelos PFC, Sperb AF, Monteiro HAO et al (2003) Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul State, Brazil, in the Southern Cone. Trans R Soc Trop Med Hyg 97:60–62

    Article  PubMed  Google Scholar 

  • Vasconcelos PFC, Bryant JE, Travassos da Rosa APA et al (2004) Genetic divergence and dispersal of yellow fever virus, Brazil. Emerg Infect Dis 10:1578–1584

    Article  PubMed  PubMed Central  Google Scholar 

  • Weidmann M, Faye OUS, Faye OUM et al (2010) Improved DNA probe based assay for the detection of African and South-American Yellow Fever Virus strains. J Clin Virol 48:187–192

    Article  CAS  PubMed  Google Scholar 

  • WHO (2010a) WHO working group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13–14 May 2009. Vaccine 28:8236–8245

    Article  Google Scholar 

  • WHO (2010b) Yellow fever surveillance and outbreak response: revision of case definitions, October 2010. Wkly Epidemiol Rec 85:465–472

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Reference Laboratory of Arboviruses, Evandro Chagas Institute, Rodovia BR 316, Km 07, S/N, 67030-000, Ananindeua, Brazil

    Pedro F. C. Vasconcelos

  2. National Institute of Science and Technology for Viral Hemorrhagic Fevers, Rodovia BR 316, Km 07, S/N, 67030-000, Ananindeua, Brazil

    Pedro F. C. Vasconcelos

  3. PAHO/WHO Collaborating Center for Arbovirus Research and Diagnostic Reference, Evandro Chagas Institute, Ministry of Health, Rodovia BR 316, Km 07, S/N, 67030-000, Ananindeua, Brazil

    Pedro F. C. Vasconcelos

  4. Department of Pathology, Pará State University, Belém, Pará, Brazil

    Pedro F. C. Vasconcelos

Authors
  1. Pedro F. C. Vasconcelos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro F. C. Vasconcelos .

Editor information

Editors and Affiliations

  1. Department of Microbiology Immunology and Parasitology Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil

    Carlos Brisola Marcondes

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Vasconcelos, P.F.C. (2017). Yellow Fever. In: Marcondes, C. (eds) Arthropod Borne Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-13884-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13884-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13883-1

  • Online ISBN: 978-3-319-13884-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation